Xeris Biopharma (XERS) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.14
-0.09
-0.05
0

Details

Expected EPS
-0.106
Actual EPS
-0.14
Surprise EPS
-0.03
Surprise Percent
+32.08%

Description

Xeris Biopharma (XERS) has reported earnings of -0.14 per share for Q2 2024.

0 Comments

Share your thoughts